-
Fund Dashboard
- Holdings
T. Rowe Price Health Sciences Portfolio
Fund Profile
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
LLY Eli Lilly and Company | 79.12 mm | 89.31 k shares | 10.47 | Common equity | Long | USA |
UNH UnitedHealth Group Incorporated | 54.43 mm | 93.10 k shares | 7.20 | Common equity | Long | USA |
TMO Thermo Fisher Scientific Inc. | 37.69 mm | 60.93 k shares | 4.99 | Common equity | Long | USA |
ISRG Intuitive Surgical, Inc. | 35.64 mm | 72.54 k shares | 4.72 | Common equity | Long | USA |
DHR Danaher Corporation | 30.12 mm | 108.33 k shares | 3.99 | Common equity | Long | USA |
SYK Stryker Corporation | 26.75 mm | 74.05 k shares | 3.54 | Common equity | Long | USA |
MRK Merck & Co., Inc. | 23.04 mm | 202.93 k shares | 3.05 | Common equity | Long | USA |
ELV Elevance Health Inc. | 22.25 mm | 42.79 k shares | 2.94 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 21.85 mm | 20.79 k shares | 2.89 | Common equity | Long | USA |
ARGX argenx SE | 21.32 mm | 39.33 k shares | 2.82 | Common equity | Long | Netherlands |
VRTX Vertex Pharmaceuticals Incorporated | 17.74 mm | 38.15 k shares | 2.35 | Common equity | Long | USA |
ALNY Alnylam Pharmaceuticals, Inc. | 17.56 mm | 63.84 k shares | 2.32 | Common equity | Long | USA |
AMGN Amgen Inc. | 16.27 mm | 50.51 k shares | 2.15 | Common equity | Long | USA |
ASTRAZENECA PLC
|
15.17 mm | 194.76 k shares | 2.01 | Common equity | Long | UK |
Cigna Holding Co | 12.85 mm | 37.08 k shares | 1.70 | Common equity | Long | USA |
BSX Boston Scientific Corporation | 12.68 mm | 151.30 k shares | 1.68 | Common equity | Long | USA |
INSM Insmed Incorporated | 9.06 mm | 124.15 k shares | 1.20 | Common equity | Long | USA |
HCA HCA Healthcare, Inc. | 8.58 mm | 21.12 k shares | 1.14 | Common equity | Long | USA |
NVO Novo Nordisk A/S | 8.32 mm | 69.92 k shares | 1.10 | Common equity | Long | Denmark |
MOH Molina Healthcare, Inc. | 8.32 mm | 24.15 k shares | 1.10 | Common equity | Long | USA |
BGNE BeiGene, Ltd. | 8.09 mm | 36.04 k shares | 1.07 | Common equity | Long | Cayman Islands |
BDX Becton, Dickinson and Company | 8.04 mm | 33.34 k shares | 1.06 | Common equity | Long | USA |
TEMPUS LABS INC CVT PFD SR D PP | 7.32 mm | 129.30 k shares | 0.97 | Preferred equity | Long | USA |
T. Rowe Price Government Reserve Fund | 6.97 mm | 6.97 mm shares | 0.92 | Short-term investment vehicle | Long | USA |
THC Tenet Healthcare Corporation | 6.76 mm | 40.67 k shares | 0.89 | Common equity | Long | USA |
ASND Ascendis Pharma A/S | 6.59 mm | 44.12 k shares | 0.87 | Common equity | Long | Denmark |
BPMC Blueprint Medicines Corporation | 6.57 mm | 70.98 k shares | 0.87 | Common equity | Long | USA |
PCVX Vaxcyte, Inc. | 6.31 mm | 55.21 k shares | 0.83 | Common equity | Long | USA |
RNA Avidity Biosciences, Inc. | 5.73 mm | 124.69 k shares | 0.76 | Common equity | Long | USA |
PEN Penumbra, Inc. | 5.59 mm | 28.76 k shares | 0.74 | Common equity | Long | USA |
A Agilent Technologies, Inc. | 4.95 mm | 33.33 k shares | 0.65 | Common equity | Long | USA |
BIOHAVEN LTD
|
4.49 mm | 89.94 k shares | 0.59 | Common equity | Long | Virgin Islands (British) |
SNY Sanofi | 3.80 mm | 65.93 k shares | 0.50 | Common equity | Long | France |
EXAS Exact Sciences Corporation | 3.61 mm | 53.05 k shares | 0.48 | Common equity | Long | USA |
NBIX Neurocrine Biosciences, Inc. | 3.58 mm | 31.03 k shares | 0.47 | Common equity | Long | USA |
CHUGAI PHARMACEUTICAL CO LTD
|
3.54 mm | 73.10 k shares | 0.47 | Common equity | Long | Japan |
EW Edwards Lifesciences Corporation | 3.20 mm | 48.46 k shares | 0.42 | Common equity | Long | USA |
RVMD Revolution Medicines, Inc. | 3.15 mm | 69.48 k shares | 0.42 | Common equity | Long | USA |
MLTX MoonLake Immunotherapeutics | 3.15 mm | 62.48 k shares | 0.42 | Common equity | Long | Cayman Islands |
SONOVA HOLDING AG
|
3.07 mm | 8.53 k shares | 0.41 | Common equity | Long | Switzerland |
ACLX Arcellx, Inc. | 3.07 mm | 36.79 k shares | 0.41 | Common equity | Long | USA |
TECH Bio-Techne Corporation | 3.04 mm | 38.09 k shares | 0.40 | Common equity | Long | USA |
OSCR Oscar Health, Inc. | 3.00 mm | 141.68 k shares | 0.40 | Common equity | Long | USA |
HOLX Hologic, Inc. | 2.86 mm | 35.16 k shares | 0.38 | Common equity | Long | USA |
AGIO Agios Pharmaceuticals, Inc. | 2.84 mm | 64.00 k shares | 0.38 | Common equity | Long | USA |
KYMR Kymera Therapeutics, Inc. | 2.76 mm | 58.40 k shares | 0.37 | Common equity | Long | USA |
ICON PLC
|
2.74 mm | 9.55 k shares | 0.36 | Common equity | Long | Ireland |
IDXX IDEXX Laboratories, Inc. | 2.73 mm | 5.40 k shares | 0.36 | Common equity | Long | USA |
RARE Ultragenyx Pharmaceutical Inc. | 2.71 mm | 48.83 k shares | 0.36 | Common equity | Long | USA |
CRNX Crinetics Pharmaceuticals, Inc. | 2.61 mm | 51.16 k shares | 0.35 | Common equity | Long | USA |
NATIONAL RESILIENCE SER B CVT PFD STOCK | 2.52 mm | 54.25 k shares | 0.33 | Preferred equity | Long | USA |
CYTK Cytokinetics, Incorporated | 2.51 mm | 47.56 k shares | 0.33 | Common equity | Long | USA |
HUM Humana Inc. | 2.47 mm | 7.79 k shares | 0.33 | Common equity | Long | USA |
RVTY Revvity, Inc. | 2.45 mm | 19.18 k shares | 0.32 | Common equity | Long | USA |
IONS Ionis Pharmaceuticals, Inc. | 2.37 mm | 59.25 k shares | 0.31 | Common equity | Long | USA |
Madrigal Pharmaceuticals, Inc. | 2.32 mm | 10.91 k shares | 0.31 | Common equity | Long | USA |
CNTA Centessa Pharmaceuticals plc | 2.31 mm | 144.28 k shares | 0.31 | Common equity | Long | UK |
NTRA Natera, Inc. | 2.22 mm | 17.50 k shares | 0.29 | Common equity | Long | USA |
PTGX Protagonist Therapeutics, Inc. | 2.18 mm | 48.33 k shares | 0.29 | Common equity | Long | USA |
GPCR Structure Therapeutics Inc. | 2.08 mm | 47.34 k shares | 0.28 | Common equity | Long | Cayman Islands |
DNLI Denali Therapeutics Inc. | 2.06 mm | 70.76 k shares | 0.27 | Common equity | Long | USA |
SARTORIUS AG | 1.96 mm | 6.98 k shares | 0.26 | Preferred equity | Long | Germany |
MCK McKesson Corporation | 1.91 mm | 3.86 k shares | 0.25 | Common equity | Long | USA |
DGX Quest Diagnostics Incorporated | 1.89 mm | 12.17 k shares | 0.25 | Common equity | Long | USA |
RGEN Repligen Corporation | 1.83 mm | 12.31 k shares | 0.24 | Common equity | Long | USA |
LBPH Longboard Pharmaceuticals, Inc. | 1.78 mm | 53.54 k shares | 0.24 | Common equity | Long | USA |
IMCR Immunocore Holdings plc | 1.71 mm | 54.92 k shares | 0.23 | Common equity | Long | UK |
CAH Cardinal Health, Inc. | 1.71 mm | 15.43 k shares | 0.23 | Common equity | Long | USA |
KRYS Krystal Biotech, Inc. | 1.70 mm | 9.33 k shares | 0.22 | Common equity | Long | USA |
ZAI LAB LTD
|
1.64 mm | 68.12 k shares | 0.22 | Common equity | Long | Cayman Islands |
LEGN Legend Biotech Corporation | 1.64 mm | 33.62 k shares | 0.22 | Common equity | Long | Cayman Islands |
APGE Apogee Therapeutics, Inc. | 1.59 mm | 27.03 k shares | 0.21 | Common equity | Long | USA |
BIIB Biogen Inc. | 1.55 mm | 7.98 k shares | 0.20 | Common equity | Long | USA |
LANTHEUS HOLDINGS INC
|
1.47 mm | 13.41 k shares | 0.19 | Common equity | Long | USA |
PRCT PROCEPT BioRobotics Corporation | 1.45 mm | 18.04 k shares | 0.19 | Common equity | Long | USA |
BMRN BioMarin Pharmaceutical Inc. | 1.44 mm | 20.47 k shares | 0.19 | Common equity | Long | USA |
SWTX SpringWorks Therapeutics, Inc. | 1.43 mm | 44.69 k shares | 0.19 | Common equity | Long | USA |
BCYC Bicycle Therapeutics plc | 1.42 mm | 62.85 k shares | 0.19 | Common equity | Long | UK |
CNC Centene Corporation | 1.41 mm | 18.76 k shares | 0.19 | Common equity | Long | USA |
NOVOCURE LTD
|
1.27 mm | 81.06 k shares | 0.17 | Common equity | Long | Jersey |
CLDX Celldex Therapeutics, Inc. | 1.26 mm | 37.10 k shares | 0.17 | Common equity | Long | USA |
TXG 10x Genomics, Inc. | 1.25 mm | 55.28 k shares | 0.17 | Common equity | Long | USA |
DXCM DexCom, Inc. | 1.22 mm | 18.24 k shares | 0.16 | Common equity | Long | USA |
BTSG BrightSpring Health Services, Inc. Common Stock | 1.20 mm | 81.70 k shares | 0.16 | Common equity | Long | USA |
COR Cencora | 1.20 mm | 5.33 k shares | 0.16 | Common equity | Long | USA |
CRGX CARGO Therapeutics, Inc. Common Stock | 1.17 mm | 63.59 k shares | 0.16 | Common equity | Long | USA |
ORUKA THERAP/ARCA BIO INC PIPE PP
|
1.10 mm | 47.12 k shares | 0.15 | Common equity | Long | USA |
IMNM Immunome, Inc. | 1.09 mm | 74.54 k shares | 0.14 | Common equity | Long | USA |
DYN Dyne Therapeutics, Inc. | 1.07 mm | 29.69 k shares | 0.14 | Common equity | Long | USA |
GENERATE BIO SER B CVT PFD STOCK PP | 1.00 mm | 84.49 k shares | 0.13 | Preferred equity | Long | USA |
EIKON THERA SERIES B CVT PFD STOCK PP | 984.25 k | 45.78 k shares | 0.13 | Preferred equity | Long | USA |
RCKT Rocket Pharmaceuticals, Inc. | 949.08 k | 51.39 k shares | 0.13 | Common equity | Long | USA |
INSP Inspire Medical Systems, Inc. | 914.90 k | 4.34 k shares | 0.12 | Common equity | Long | USA |
TREELINE BIO SER A CVT PFD STOCK PP | 913.22 k | 106.06 k shares | 0.12 | Preferred equity | Long | USA |
MBX BIOSCIENCES SER C CVT PFD PP | 901.18 k | 34.69 k shares | 0.12 | Preferred equity | Long | USA |
NATIONAL RESILIENCE SER C CVT PFD STOCK | 893.34 k | 19.22 k shares | 0.12 | Preferred equity | Long | USA |
BRKR Bruker Corporation | 883.00 k | 12.79 k shares | 0.12 | Common equity | Long | USA |
BLUEJAY THERAPEUTICS SER C CVT PFD PP | 850.15 k | 130.26 k shares | 0.11 | Preferred equity | Long | USA |
AKRO Akero Therapeutics, Inc. | 841.22 k | 29.32 k shares | 0.11 | Common equity | Long | USA |
REPL Replimune Group, Inc. | 786.33 k | 71.75 k shares | 0.10 | Common equity | Long | USA |
IGMS IGM Biosciences, Inc. | 763.57 k | 46.17 k shares | 0.10 | Common equity | Long | USA |
IMTX Immatics N.V. | 762.66 k | 66.84 k shares | 0.10 | Common equity | Long | Netherlands |
IDYA IDEAYA Biosciences, Inc. | 753.07 k | 23.77 k shares | 0.10 | Common equity | Long | USA |
DELFI DIAGNOSTICS SR A CVT PFD STOCK PP | 748.76 k | 154.53 k shares | 0.10 | Preferred equity | Long | USA |
INSITRO SER B CVT PFD PP | 727.86 k | 39.79 k shares | 0.10 | Preferred equity | Long | USA |
XNCR Xencor, Inc. | 679.72 k | 33.80 k shares | 0.09 | Common equity | Long | USA |
CELLANOME SERIES A CVT PFD STOCK PP | 672.89 k | 89.84 k shares | 0.09 | Preferred equity | Long | USA |
ARSENAL BIOSCIENCES SER C CVT PFD PP | 650.73 k | 35.02 k shares | 0.09 | Preferred equity | Long | USA |
IMCR Immunocore Holdings plc | 637.85 k | 739.00 k principal | 0.08 | Debt | Long | UK |
IOVA Iovance Biotherapeutics, Inc. | 623.02 k | 66.35 k shares | 0.08 | Common equity | Long | USA |
CARIS LIFE SCIENCES SER C CVT PFD PP | 616.17 k | 169.28 k shares | 0.08 | Preferred equity | Long | USA |
CHROMA MEDICINE SERIES A CVT PFD STOCK P | 613.02 k | 235.78 k shares | 0.08 | Preferred equity | Long | USA |
SRRK Scholar Rock Holding Corporation | 605.41 k | 75.58 k shares | 0.08 | Common equity | Long | USA |
ANAB AnaptysBio, Inc. | 599.65 k | 17.90 k shares | 0.08 | Common equity | Long | USA |
WAVE LIFE SCIENCES LTD
|
597.32 k | 72.84 k shares | 0.08 | Common equity | Long | Singapore |
RAPPORT THERAPEUTICS INC
|
576.45 k | 28.15 k shares | 0.08 | Common equity | Long | USA |
END EAVOR BIO SERIES B CVT PFD STOCK PP | 550.05 k | 84.30 k shares | 0.07 | Preferred equity | Long | USA |
AKTIS ONCOLOGY SER B CVTPFD PP | 537.91 k | 134.48 k shares | 0.07 | Preferred equity | Long | USA |
CLEAR LABS SERIES C CVT PFD PP | 531.46 k | 171.44 k shares | 0.07 | Preferred equity | Long | USA |
ARVN Arvinas, Inc. | 524.77 k | 21.31 k shares | 0.07 | Common equity | Long | USA |
NUTCRACKER THERA SER C CVT PFD STOCK PP | 500.66 k | 46.57 k shares | 0.07 | Preferred equity | Long | USA |
KARTOS THERAPEUTICS SR C CVT PFD STK PP | 485.75 k | 85.93 k shares | 0.06 | Preferred equity | Long | USA |
INSITRO SER C CVT PFD PP | 480.73 k | 26.28 k shares | 0.06 | Preferred equity | Long | USA |
IRON Disc Medicine, Inc. | 477.94 k | 9.73 k shares | 0.06 | Common equity | Long | USA |
KARDIUM SERIES D6 CVT PFD STOCK PP | 473.03 k | 556.50 k shares | 0.06 | Preferred equity | Long | USA |
GENESIS THERA SEV B CVT PFD STOCK PP | 465.32 k | 91.10 k shares | 0.06 | Preferred equity | Long | USA |
SYRE Spyre Therapeutics, Inc. | 449.38 k | 15.28 k shares | 0.06 | Common equity | Long | USA |
ALLO Allogene Therapeutics, Inc. | 449.03 k | 160.37 k shares | 0.06 | Common equity | Long | USA |
OBSIDIAN THERAPEUTICS SR C CVT PFD STK PP | 422.06 k | 222.39 k shares | 0.06 | Preferred equity | Long | USA |
PROTHENA CORP PLC
|
408.93 k | 24.44 k shares | 0.05 | Common equity | Long | Ireland |
DELFI DIAGNOSTICS SR B CVT PFD STOCK PP | 407.53 k | 84.10 k shares | 0.05 | Preferred equity | Long | USA |
SANA Sana Biotechnology, Inc. | 396.71 k | 95.36 k shares | 0.05 | Common equity | Long | USA |
FREENOME HOLDINGS SER B CVT PFD PP | 396.25 k | 71.40 k shares | 0.05 | Preferred equity | Long | USA |
LYEL Lyell Immunopharma, Inc. | 393.71 k | 285.30 k shares | 0.05 | Common equity | Long | USA |
RLAY Relay Therapeutics, Inc. | 382.45 k | 54.02 k shares | 0.05 | Common equity | Long | USA |
ELEMENT BIOSCIENCES SER C CVT PFD STOCK | 375.80 k | 38.78 k shares | 0.05 | Preferred equity | Long | USA |
CARIS LIFE SER D CVT PFD STOCK PP | 371.06 k | 101.94 k shares | 0.05 | Preferred equity | Long | USA |
DNA SCRIPT SERIES C CVT PFD STOCK PP | 363.51 k | 1.13 k shares | 0.05 | Preferred equity | Long | France |
TESSERA THERAPEUTICS SR C CVT PFD STK PP | 357.36 k | 17.48 k shares | 0.05 | Preferred equity | Long | USA |
VERILY LIFE SCIENCES LLC SER B UNITS PP
|
351.10 k | 5.22 k shares | 0.05 | Common equity | Long | USA |
KARDIUM INC SER D-5 CVT PFD STOCK PP | 343.21 k | 403.78 k shares | 0.05 | Preferred equity | Long | USA |
TENAX THERAPEUTICS PRE FUNDED WTS PP
|
334.37 k | 101.92 k shares | 0.04 | Common equity | Long | USA |
SALUDA MEDICAL SERIES D CVT PFD STOCK PP | 331.39 k | 31.15 k shares | 0.04 | Preferred equity | Long | USA |
APLS Apellis Pharmaceuticals, Inc. | 327.65 k | 11.36 k shares | 0.04 | Common equity | Long | USA |
TRDA Entrada Therapeutics, Inc. | 317.27 k | 19.85 k shares | 0.04 | Common equity | Long | USA |
PLRX Pliant Therapeutics, Inc. | 308.69 k | 27.54 k shares | 0.04 | Common equity | Long | USA |
GALVANIZE THERAPEUTICS CVT PROM NOTE PP | 295.30 k | 295.30 k principal | 0.04 | Debt | Long | USA |
AVALYN PHARMA SER C-1 CVT PFD STOCK PP | 284.58 k | 388.60 k shares | 0.04 | Preferred equity | Long | USA |
GLUE Monte Rosa Therapeutics, Inc. | 280.78 k | 52.98 k shares | 0.04 | Common equity | Long | USA |
SCRIBE THERA SER B CVT PFD STOCK PP | 277.64 k | 45.88 k shares | 0.04 | Preferred equity | Long | USA |
ODYSSEY THERAPEUTICS SR B CVT PFD STK PP | 262.95 k | 50.57 k shares | 0.03 | Preferred equity | Long | USA |
REFLEXION MEDICAL INC CVT PFD SR C PP | 259.22 k | 150.71 k shares | 0.03 | Preferred equity | Long | USA |
KARDIUM INC CB CVT PROM NOTE PP | 256.50 k | 256.50 k principal | 0.03 | Debt | Long | Canada |
VYGR Voyager Therapeutics, Inc. | 250.44 k | 42.81 k shares | 0.03 | Common equity | Long | USA |
AFFINIVAX AFX3772 MILESTONE EVENT PP
|
245.66 k | 331.98 k shares | 0.03 | Common equity | Long | USA |
COLOR HEALTH SERIES D-1 CVT PFD STOCK PP | 241.78 k | 20.17 k shares | 0.03 | Preferred equity | Long | USA |
HONOR TECHNOLOGY SER D CVT PFD PP | 240.82 k | 140.83 k shares | 0.03 | Preferred equity | Long | USA |
SIONNA THERAPEUTICS SR B CVT PFD STK PP | 238.77 k | 24.46 k shares | 0.03 | Preferred equity | Long | USA |
EYPT EyePoint Pharmaceuticals, Inc. | 236.18 k | 29.56 k shares | 0.03 | Common equity | Long | USA |
COLOR HEALTH SER D CVT PFD STOCK PP | 235.59 k | 13.31 k shares | 0.03 | Preferred equity | Long | USA |
SALUDA MEDICAL INC SERIES E CVT PFD PP | 234.79 k | 24.28 k shares | 0.03 | Preferred equity | Long | USA |
FREENOME HOLDINGS SER C CVT PFD PP | 231.61 k | 41.73 k shares | 0.03 | Preferred equity | Long | USA |
GBIO Generation Bio Co. | 225.90 k | 91.46 k shares | 0.03 | Common equity | Long | USA |
CLEERLY SER C CVT PFD STK PP | 220.75 k | 26.53 k shares | 0.03 | Preferred equity | Long | USA |
THIRD ARC BIO SER A CVT PFD PP | 213.73 k | 101.57 k shares | 0.03 | Preferred equity | Long | USA |
ARDX Ardelyx, Inc. | 209.88 k | 30.46 k shares | 0.03 | Common equity | Long | USA |
LUMICKS TECH SER D CVT PFD STOCK PP | 204.84 k | 221.00 shares | 0.03 | Preferred equity | Long | USA |
FOG PHARMA SER D CVT PFD STOCK PP | 202.26 k | 27.55 k shares | 0.03 | Preferred equity | Long | USA |
RING THERA SER B CVT PFD STOCK PP | 201.87 k | 43.89 k shares | 0.03 | Preferred equity | Long | USA |
GENERATE BIOMEDICINES INC SER C CVT PFD | 201.49 k | 17.00 k shares | 0.03 | Preferred equity | Long | USA |
CHROMA MEDICINE SER B CVT PFT STOCK PP | 197.85 k | 76.10 k shares | 0.03 | Preferred equity | Long | USA |
EIKON THERAPEUTICS SER C CVT PFD STK PP | 195.04 k | 9.07 k shares | 0.03 | Preferred equity | Long | USA |
GENESIS THERA SER A CVT PFD STOCK PP | 191.39 k | 37.47 k shares | 0.03 | Preferred equity | Long | USA |
FOG PHARMACEUTICALS SERIES C CVT PFD STOCK PP | 165.37 k | 19.48 k shares | 0.02 | Preferred equity | Long | USA |
ORUKA THERAPEUTICS INC PIPE 9/24 PP
|
162.48 k | 6.98 k shares | 0.02 | Common equity | Long | USA |
HONOR TECHNOLOGY SER E CVT PFD STOCK PP | 162.31 k | 94.92 k shares | 0.02 | Preferred equity | Long | USA |
AURA Aura Biosciences, Inc. | 159.22 k | 17.87 k shares | 0.02 | Common equity | Long | USA |
PAX LABS CLASS A COMMON PP
|
158.13 k | 385.68 k shares | 0.02 | Common equity | Long | USA |
ENDEAVOR BIO SER C CVT PFD PP | 154.16 k | 23.63 k shares | 0.02 | Preferred equity | Long | USA |
REFLEXION MEDICAL INC SR E CVT PFD PP | 150.94 k | 83.86 k shares | 0.02 | Preferred equity | Long | USA |
ALEC Alector, Inc. | 141.58 k | 30.38 k shares | 0.02 | Common equity | Long | USA |
CFRXQ ContraFect Corporation | 138.30 k | 81.35 k shares | 0.02 | Common equity | Long | USA |
SALIOGEN THERA SERIES B CVT PFD STOCK PP | 136.53 k | 4.69 k shares | 0.02 | Preferred equity | Long | USA |
FREENOME HOLDINGS SER D CVT PFD PP | 131.84 k | 23.67 k shares | 0.02 | Preferred equity | Long | USA |
OBIO Orchestra BioMed Holdings, Inc. | 127.38 k | 24.78 k shares | 0.02 | Common equity | Long | USA |
AFFINIVAX NEXT GEN PROD MILESTON EVNT PP
|
122.83 k | 331.98 k shares | 0.02 | Common equity | Long | USA |
INSCRIPTA SERIES E CVT PFD STOCK PP | 121.06 k | 64.74 k shares | 0.02 | Preferred equity | Long | USA |
LARONDE SERIES B CVT PFD STOCK PP | 115.58 k | 52.54 k shares | 0.02 | Preferred equity | Long | USA |
ZNTL Zentalis Pharmaceuticals, Inc. | 111.38 k | 30.27 k shares | 0.01 | Common equity | Long | USA |
REFLEXION MEDICAL INC PP | 109.93 k | 83.28 k shares | 0.01 | Preferred equity | Long | USA |
ELEMENT BIOSCIENCES SER D-1 CVT PFD PP | 106.32 k | 13.56 k shares | 0.01 | Preferred equity | Long | USA |
ELEMENT BIOSCIENCES SER D CVT PFD PP | 106.32 k | 13.56 k shares | 0.01 | Preferred equity | Long | USA |
SAGE Sage Therapeutics, Inc. | 104.57 k | 14.48 k shares | 0.01 | Common equity | Long | USA |
RING THERAPEUTICS SER C CVT PFD STK PP | 98.82 k | 21.48 k shares | 0.01 | Preferred equity | Long | USA |
ARBOR BIO SERIES B CVT PFD STOCK PP | 98.62 k | 23.99 k shares | 0.01 | Preferred equity | Long | USA |
- EXACT SCIENCES CMO MILESTONE PP
|
95.43 k | 167.42 k shares | 0.01 | Common equity | Long | USA |
CAPSULE CORP SERIES E CVT PFD STOCK PP | 93.20 k | 40.88 k shares | 0.01 | Preferred equity | Long | USA |
FOG PHARMA SER E CVT PFD PP | 92.82 k | 14.90 k shares | 0.01 | Preferred equity | Long | USA |
REFLEXION MEDICAL INC CVT | 89.39 k | 51.08 k shares | 0.01 | Preferred equity | Long | USA |
PRLD Prelude Therapeutics Incorporated | 88.49 k | 42.75 k shares | 0.01 | Common equity | Long | USA |